Demo Sign up Log In

Cost of Revenue

$3.21B

TTM · Period ending: Jun 30, 2026 · USD

BIIB Cost of Revenue

Latest reported$3.21Bperiod endingJun 30, 2026

Latest reported$3.21Bperiod endingJun 30, 2026

BIIB TTM Cost of Revenue ($0.00 → $3.21B)

TTM cost of revenue

High-resolution chart · PNG

BIIB cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	130,128,000
Mar 31, 2001	125,721,000
Dec 31, 2000	125,198,000
Sep 30, 2000	145,750,000
Jun 30, 2000	134,123,000
Mar 31, 2000	121,428,000
Dec 31, 1999	111,105,000
Sep 30, 1999	98,709,000
Jun 30, 1999	90,409,000
Mar 31, 1999	83,509,000
Dec 31, 1998	74,409,000
Sep 30, 1998	61,588,000
Jun 30, 1998	56,488,000
Mar 31, 1998	51,988,000
Dec 31, 1997	50,188,000
Sep 30, 1997	43,425,000
Jun 30, 1997	41,925,000
Mar 31, 1997	35,325,000
Dec 31, 1996	28,525,000
Sep 30, 1996	7,200,000
Jun 30, 1996	900,000
Mar 31, 1996	900,000
Dec 31, 1995	500,000
Sep 30, 1995	9,548,000
Jun 30, 1995	9,448,000
Mar 31, 1995	9,648,000
Dec 31, 1994	10,148,000
Sep 30, 1994	2,400,000
Jun 30, 1994	3,600,000
Mar 31, 1994	5,200,000
Dec 31, 1993	5,500,000
Sep 30, 1993	-39,300,000
Jun 30, 1993	-22,700,000
Mar 31, 1993	-9,400,000
Dec 31, 1992	2,300,000
Sep 30, 1992	57,600,000
Jun 30, 1992	50,900,000
Mar 31, 1992	45,700,000
Dec 31, 1991	43,300,000
Sep 30, 1991	40,300,000
Jun 30, 1991	38,400,000
Mar 31, 1991	37,800,000
Dec 31, 1990	35,500,000
Sep 30, 1990	34,000,000
Jun 30, 1990	31,500,000
Mar 31, 1990	22,100,000
Dec 31, 1989	14,100,000
Sep 30, 1989	6,800,000
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Dec 31, 1987	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.